ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 677,426$31,249,6616.12%
RTW INVESTMENTS, LP 5,405,089$249,336,7564.75%
First Light Asset Management, LLC 589,963$27,214,9932.13%
Rock Springs Capital Management LP 1,384,269$63,856,3291.52%
Avidity Partners Management LP 900,700$41,549,2911.45%
SUVRETTA CAPITAL MANAGEMENT, LLC 541,480$24,978,4721.34%
SPHERA FUNDS MANAGEMENT LTD. 183,696$8,473,8961.32%
CHI Advisors LLC 85,000$3,921,0501.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 80,052$3,691,1981.12%
EMERALD ADVISERS, LLC 552,136$25,470,0341.11%
Privium Fund Management B.V. 112,241$5,236,0421.10%
EMERALD MUTUAL FUND ADVISERS TRUST 440,141$20,303,7041.10%
SECTOR GAMMA AS 100,605$4,640,9091.04%
Ikarian Capital, LLC 121,658$5,612,0840.89%
AlphaCentric Advisors LLC 28,500$1,314,7050.73%
EFG Asset Management (North America) Corp. 53,671$2,475,5750.53%
Avoro Capital Advisors LLC 750,000$34,597,5000.47%
Sands Capital Management 2,673,638$123,334,9210.38%
Motley Fool Asset Management LLC 91,688$4,229,5670.38%
Motley Fool Wealth Management, LLC 110,120$5,080,0680.30%
External links

This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.